If you are considering genetic testing for inherited breast cancer risk, wondering about accuracy is probably one of your first questions. And it is a good one. The short answer is that clinical-grade hereditary breast cancer genetic testing is highly accurate, with over 99% sensitivity for detecting a gene mutation when it is present. While important, accuracy shouldn't be your only consideration; understanding what the result actually tells you is just as important as knowing how reliably the test can find what is there.
This article explains what accuracy means in the context of breast cancer risk genetic testing, what a positive result means, what a negative result does and does not rule out, and what happens when a result falls somewhere in between.
What Does Accuracy Mean in Genetic Testing?
When people ask how accurate genetic testing is, they are usually asking two different questions without realizing it:
Does the test reliably find a mutation when one is present? This is called analytical accuracy and measures how well the laboratory technology performs.
What does the result actually tell me about my cancer risk? This is called clinical accuracy, and it is about interpretation: what a positive or negative result means for you specifically, given your age, family history, and which genes were tested.
Both matter. A test can be analytically excellent yet yield results that are confusing or misunderstood without proper clinical guidance. This is why genetic counseling, before and after testing, is such an important part of the process. It is what turns a number into a plan.
How Accurate Is the Test at Finding a Mutation?
Hereditary breast cancer risk genetic testing performed in CAP-accredited, CLIA-certified laboratories has an analytical accuracy of 99% or higher for detecting pathogenic variants in the genes tested. This level of accuracy reflects: (NCI, Genetic Testing Fact Sheet)
If a harmful inherited gene mutation is present in your DNA, the test will almost certainly detect it.
If no harmful mutation is present, the test will almost certainly confirm that.
False positives, meaning the test reports a mutation that is not actually there, are extremely rare in clinical-grade testing.
This level of accuracy is why results from certified laboratories can be used to make real clinical decisions, such as whether to begin enhanced breast cancer surveillance or to discuss preventive options. Not all genetic tests on the market are performed in certified laboratories. For clinically meaningful results, laboratory certification is the first thing to verify.
Clinical-Grade Genetic Testing Has High Analytical Accuracy
99%+
analytical accuracy for detecting a hereditary gene mutation
That means if a mutation is present in your DNA, a clinical-grade test from a certified laboratory will almost certainly find it. And if there is no mutation, the test will almost certainly confirm that.
This applies to tests performed by CAP-accredited, CLIA-certified laboratories. The quality standards required for clinical-grade genetic testing.
Source: NCI
What Does a Positive Result Actually Mean?
A positive result means a harmful inherited gene mutation was identified in one of the genes tested.
Here is what that does and does not tell you:
The specific mutation identified is associated with significantly elevated lifetime breast cancer risk. For BRCA1, the lifetime risk is up to 72%; for BRCA2, approximately 69%. (American Cancer Society)
The mutation is present in every cell of your body. It was there from birth, inherited from one of your parents.
A positive result does not mean cancer is certain. Many people who carry inherited gene mutations live their full lives without developing cancer. The mutation creates a vulnerability, not a diagnosis.
The clinical value of a positive result is the information it provides and the options it can make available. Evidence-based monitoring options like annual breast MRI alongside mammography, risk-reducing medications, and conversations about preventive surgery are only available to people who know their status.
A positive result gives you access to those options. Not knowing does not protect you from the risk. It leaves you without the tools to manage it.
What Does a Negative Result Actually Mean?
A negative result means no harmful inherited gene mutation was found in the genes tested.
This is meaningfully reassuring, but it comes with important context:
No mutation was identified in the genes the panel tested. This substantially reduces the probability of a hereditary breast cancer syndrome driven by those genes.
It does not mean all hereditary cancer risk has been eliminated. Genes not included in the panel have not been assessed. And sporadic breast cancer, the kind not caused by inherited mutations, can still develop.
If a specific mutation is already confirmed in a close family member, a general panel test may not be the right approach. A more targeted test for that specific mutation is more appropriate in that situation. A genetic counselor can advise on this.
For people with a strong family history, a negative result does not necessarily mean all monitoring stops. A genetic counselor may still recommend surveillance based on the family pattern, even without a confirmed mutation.
Variants of Uncertain Significance: How Common Are They?
Some genetic test results fall into a third category called a variant of uncertain significance, often referred to as a VUS.
A VUS is a DNA change identified during testing, but current science does not yet have sufficient evidence to definitively determine whether it is harmful or harmless. Think of it like a word that has not yet made it into the dictionary. The word exists, but researchers are still working out exactly what it means clinically.
A VUS is not a positive result. It should not be treated as one.
It does not confirm elevated cancer risk.
Some laboratories choose not to report VUS findings at all because they are not clinically actionable. If your lab does not report VUS results, your genetic counselor will focus only on findings that have a clear next step.
Does the Type of Test Affect Accuracy?
BRCA-Only vs. Comprehensive Panel
Both a BRCA-only test and a comprehensive multi-gene panel performed by a clinical laboratory achieve the same high analytical accuracy for the genes they cover. The difference is not in how accurately they test. It is how much they test.
A BRCA-only test that comes back negative only tells you that BRCA1 and BRCA2 mutations are not present. It says nothing about PALB2, ATM, CHEK2, Lynch syndrome genes, or other genes that significantly elevate breast cancer risk. A comprehensive panel covering 25 to 35 genes addresses more of the hereditary cancer risk question from a single sample. If BRCA comes back negative but PALB2 does not, you need the multi-gene panel to know that.
Laboratory Certification
The most important factor in test accuracy is where the test is performed. Clinical-grade hereditary breast cancer testing requires both CAP accreditation and CLIA certification. These are the quality standards that ensure results are reliable enough to inform medical decisions. Laboratories performing direct-to-consumer genetic tests may not hold both certifications, which affects both the reliability of mutation detection and physicians' acceptance of results for clinical use.
FAQ: Accuracy of Breast Cancer Genetic Testing
Can breast cancer genetic risk testing give a false positive?
False positives, meaning the test reports a mutation that is not actually present, are extremely rare in clinical-grade testing from certified laboratories. What can happen is a result called a VUS (variant of uncertain significance). A VUS is different from a false positive. It is a real DNA variant that was detected. The uncertainty is about what it means clinically, not whether it is there. A genetic counselor helps you understand the difference if your test reports VUS’s.
Can the test miss a mutation?
There are two ways a test can miss a mutation. The first is an analytical miss, failing to detect a mutation that is present in the genes being tested. This is extremely rare, less than 1 percent, in certified laboratories. The second is a scope miss: the mutation is not detected because it is in a gene not included in the panel. This is why comprehensive multi-gene panels are preferred over single-gene testing. A panel that covers 25 to 35 genes identifies mutations that a BRCA-only test would miss entirely.
Is a genetic test for breast cancer the same as a mammogram?
No. They serve completely different purposes. A mammogram is an imaging test that looks for signs of breast cancer that may already be present. It is a screening tool used repeatedly. Genetic testing analyzes your inherited DNA to identify gene mutations that elevate your lifetime risk of developing breast cancer in the future. Genetic testing is done once, and the results are relevant for life. The two tools complement each other rather than replacing one another.
Accurate Testing Is Only the Beginning. Knowing What to Do With It Is What Matters.
Hereditary breast cancer genetic risk testing is highly accurate. But the clinical value of that accuracy depends on what you do with the result. A positive result without a team behind it provides no protection. A misunderstood negative result creates false reassurance.
The test result provides the clinical information. Genetic counseling helps interpret that information in the context of your personal and family history and translate it into a clear, documented path forward. Having both testing and counseling in one program is an efficient way to move from concern about family history to informed next steps with your healthcare team.
Kadance exists to make that possible. Members receive hereditary cancer risk testing across 26 clinically actionable genes, genetic counseling to interpret positive results, and a documented plan their physician can act on. If breast cancer has appeared in your family, the question is not whether testing is worth it. It is when you want to find out.
Take control of your health with the most accurate genetic testing available.
Explore Kadance membership for access to hereditary cancer risk testing and genetic counseling, supported by a precision health framework that ensures results are understood and acted on, not just reported.
The information in this article is intended for educational purposes only and does not constitute medical advice. It may not fully reflect the current scope of Kadance services, testing panels, or program offerings. For the most accurate and up-to-date information about what Kadance includes, please visit kadance.com or speak with a member of our team.
.svg)
